5x33
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5x33' size='340' side='right' caption='[[5x33]], [[Resolution|resolution]] 3.70Å' scene=''> | <StructureSection load='5x33' size='340' side='right' caption='[[5x33]], [[Resolution|resolution]] 3.70Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5x33]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5X33 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5X33 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5x33]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Cavpo Cavpo]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5X33 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5X33 FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7Y9:4-[[3-[[4-[2-(4-hydroxyphenyl)propan-2-yl]phenoxy]methyl]phenyl]methoxy]benzenecarboximidamide'>7Y9</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7Y9:4-[[3-[[4-[2-(4-hydroxyphenyl)propan-2-yl]phenoxy]methyl]phenyl]methoxy]benzenecarboximidamide'>7Y9</scene></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">Ltb4r ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10141 CAVPO])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Lysozyme Lysozyme], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.17 3.2.1.17] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5x33 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5x33 OCA], [http://pdbe.org/5x33 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5x33 RCSB], [http://www.ebi.ac.uk/pdbsum/5x33 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5x33 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5x33 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5x33 OCA], [http://pdbe.org/5x33 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5x33 RCSB], [http://www.ebi.ac.uk/pdbsum/5x33 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5x33 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Most G-protein-coupled receptors (GPCRs) are stabilized in common in the inactive state by the formation of the sodium ion-centered water cluster with the conserved Asp(2.50) inside the seven-transmembrane domain. We determined the crystal structure of the leukotriene B4 (LTB4) receptor BLT1 bound with BIIL260, a chemical bearing a benzamidine moiety. Surprisingly, the amidine group occupies the sodium ion and water locations, interacts with D66(2.50), and mimics the entire sodium ion-centered water cluster. Thus, BLT1 is fixed in the inactive state, and the transmembrane helices cannot change their conformations to form the active state. Moreover, the benzamidine molecule alone serves as a negative allosteric modulator for BLT1. As the residues involved in the benzamidine binding are widely conserved among GPCRs, the unprecedented inverse-agonist mechanism by the benzamidine moiety could be adapted to other GPCRs. Consequently, the present structure will enable the rational development of inverse agonists specific for each GPCR. | ||
| + | |||
| + | Na(+)-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1.,Hori T, Okuno T, Hirata K, Yamashita K, Kawano Y, Yamamoto M, Hato M, Nakamura M, Shimizu T, Yokomizo T, Miyano M, Yokoyama S Nat Chem Biol. 2018 Jan 8. pii: nchembio.2547. doi: 10.1038/nchembio.2547. PMID:29309055<ref>PMID:29309055</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 5x33" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Cavpo]] | ||
[[Category: Lysozyme]] | [[Category: Lysozyme]] | ||
[[Category: Hirata, K]] | [[Category: Hirata, K]] | ||
Revision as of 06:45, 7 February 2018
Leukotriene B4 receptor BLT1 in complex with BIIL260
| |||||||||||
Categories: Cavpo | Lysozyme | Hirata, K | Hori, T | Kawano, Y | Yamamoto, M | Yamashita, K | Yokoyama, S | Helix | Membrane protein
